About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

ARC in Hemorrhagic Stroke | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT02386202

ARC in Hemorrhagic Stroke

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Lead sponsor: University of North Carolina, Chapel Hill•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of North Carolina, Chapel Hill

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults ≥ 18 years
•Patients with hemorrhagic stroke
•Anticipated length of stay in the neuroscience intensive care unit \> 48 hours
•Informed consent provided by the patient or by the patient's designated medical proxy

Exclusion Criteria

•Pregnancy
•Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5)
•Patients receiving renal replacement therapy
•Patients with an admission serum creatinine \> 1.4 mg/dL
•Patients with non-aneurysmal subarachnoid hemorrhage
•Patients with history of nephrectomy or body mass index \< 18 kg/m2

Related studies

RECRUITINGPhase 2/3

Minocycline in Stroke Study at Maimonides

NCT07237048 · Stroke, Ischemia Stroke, and more

Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Motor Performance in Stroke Individuals

NCT07236216 · Hemorrhagic Stroke, Ischemic Stroke, and more

One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy

NCT07052045 · Stroke Acute, Acute Ischemic Stroke AIS, and more

Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia

NCT06069973 · Ischemic Stroke, Hemorrhagic Stroke

RECRUITINGPhase 4

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

NCT07225101 · Wound Closure, Brain Tumor Adult, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 2, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment80

Start dateJan 2015

Last updatedDec 2, 2015

Condition

Hemorrhagic Stroke Augmented Renal Clearance

Locations shown

University of North Carolina Hospitals

Chapel Hill, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 2, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions